drugset / Trial / NCT00581100
Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate if Etanercept administered at a higher initial dose provides greater improvement in nail and skin psoriasis symptoms than a regimen with a lower initial dose.
Timeline
- Start
- 2007-09
- Primary completion
- 2009-08
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Etanercept | Protein / enzyme biologic | 50 mg | Subcutaneous |